Crit Ventures Invests in Korean-Founded U.S. Startups 'Sopo' and 'Ology Group'

Investment in K-Food 'Sopo' and K-Beauty 'Ology Group'
"Continued Investment in Early-Stage Companies with Global Competitiveness"

On March 3, venture capital firm Crit Ventures announced that it had invested in two U.S.-based K-culture startups: Kkini (hereafter referred to as Sopo), which operates the Korean fast-casual dining brand Sopo Korean Eats, and Ology Group, a K-medical beauty platform.

As part of its strategy to diversify its portfolio and strengthen profitability, Crit Ventures has targeted global markets such as North America, focusing on discovering Korean-founded startups in local markets and expanding investment in highly scalable services. After establishing a branch office in Palo Alto, Silicon Valley, U.S., last year, the company has been building its proprietary network by continuously hiring local talent and preparing for investment activities. Crit Ventures has already added Shin Star Presents (Olso) in the western United States and Early in the United Kingdom to its portfolio companies.

Sopo, one of the recent investment recipients, is a Korean fast-casual brand headquartered in Delaware, U.S. The brand features a build-your-own meal style where customers select their own rice, protein, and side dishes, and it uses locally sourced ingredients to lower the entry barrier to Korean cuisine. Sopo currently operates its first store in Manhattan, New York, and plans to expand to major cities on the U.S. East Coast-including Midtown East, Brooklyn, Washington DC, Boston, and Philadelphia-by 2029.

Ology Group is a K-medical beauty platform startup based in New York, U.S., that provides Korean-style non-invasive and minimally invasive cosmetic medical services. The company was co-founded by CEO Amy Kim, a Korean American, and Chief Science Officer Hana Jeon, a board-certified dermatologist from Harvard with over 10 years of experience in cosmetic and clinical dermatology.

Ology Group plans to expand its flagship stores based on a strategy that targets high-income consumers in the U.S. with (1) private spaces, (2) customized treatments by specialists in dermatology and cosmetic medical services, and (3) medical services such as Botox, laser, and anti-aging care, similar to those offered at high-end dermatology clinics in Korea.

Jaejun Song, CEO of Crit Ventures, commented, "As demand for Korean culture grows in the U.S. market, it is spreading beyond single content areas to the entire lifestyle sector. We will continue to invest in early-stage companies with global competitiveness, focusing on sectors closely related to K-culture such as food, beauty, and healthcare."

This content was produced with the assistance of AI translation services.